Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels

Rosiglitazone is a thiazolidinedione-class antidiabetic drug that reduces blood glucose and glycated hemoglobin levels. We here investigated the interaction of rosiglitazone with Kv3.1 expressed in Chinese hamster ovary cells using the whole-cell patch-clamp technique. Rosiglitazone rapidly and reve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyang Mi, Yoon, Seong Han, Kim, Min-Gul, Hahn, Sang June, Choi, Bok Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806636/
https://www.ncbi.nlm.nih.gov/pubmed/36575937
http://dx.doi.org/10.4196/kjpp.2023.27.1.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806636/
https://www.ncbi.nlm.nih.gov/pubmed/36575937
http://dx.doi.org/10.4196/kjpp.2023.27.1.95

Ejemplares similares